full list rate price target
earn chang report pleas see
tabl page
pt
cut altria price target effect altria manag provid
short-term bearish view stock given see unsuccess attempt
sell us busi philip morri p/core tobacco ep indic us
someth must realli wrong us market altria manag
confid state variou forum compani achiev ep growth
per annum wide rang scenario investor tri assess whether
still valid view neg develop around tobacco
sector last two year rapid growth e-cig neg impact cig
volum ever shift regulatori prioriti deadlin juul transact
vapi epidem pm-mo deal attempt bearish
logic own abi increasingli unclear stock languish
low level increasingli get question around mo continu
abi consid much valu ascrib stake pm-
mo deal stake worth mo mo own share
abi lock-up octob sold
mo want sell share might impact account abi stake
current equiti invest well two board seat abi
straightforward still would argu valu greater zero valu
free balanc sheet could help drive iqo us
opportun pm manag clarifi stanc mo ceo andr
calantzopoulo recent told cnbc mo deal forese futur
think explicit statement deal current
manag team might need help regain investor confid
strong quarter zyn result swedish match highlight
volum zyn might see sequenti stagnat benefit inventori
build-up howev sell-through strong inventori function sell
keep us zyn forecast increas
zyn forecast remain model modest sequenti
acceler post competit heat swma us flavor cigar busi
soon see advers fda regul question whether zyn growth off-set
case right
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
research report prepar whole part equiti research analyst
base outsid us registered/qualifi research analyst finra
summari rate price target earn chang report chang shown bold
barclay research share price target price shown primari list currenc ep estim shown report currenc
current fiscal year estim barclay research fiscal year estim barclay research
valuat methodolog risk
valuat methodolog set price target altria base price-to-earnings valuat last two decad altria trade averag
forward multipl higher cigarett volum declin manag attempt sell us busi p/core tobacco ep
expect pressur multipl near-term valu altria price-to-earnings add addit valu per share juul crono get
price target usd
risk may imped achiev barclay research valuat price target fda regul drastic impact
valuat methodolog set price target jt use price-to-earnings multipl set target multipl jt line averag
target multipl closest peer take account rel level growth regulatori competit risk balanc sheet strength
risk may imped achiev barclay research valuat price success launch jt reduc risk
product ploom tech roll across japan expect jt success gain signific traction market
stock could re-rat even profit remain elus near term jt also launch logic vapour product intern
market success would increment forecast
valuat methodolog set price target pmi base price-to-earnings valuat last year pmi trade low p/ntm
ep high p/ntm ep averag forward price-to-earnings pmi histor trade premium peer
continu valu pmi price-to-earnings add valu canadian subsidiari post payment ascrib liabil
result usd price target
risk may imped achiev barclay research valuat price target jt make ploom tech success
disrupt tax hike juul success intern market
valuat methodolog past two decad swma trade low p/ntm ep high p/ntm ep
averag forward price-to-earnings due swma differ busi differ growth regulatori dynam think
import think compani sotp basi valu zyn due high growth potenti expand across us
lower regulatori threat due posit risk continuum valu rest busi ev/ebitda
line industri peer adjust regulatori growth dynam arriv sek price target
risk may imped achiev barclay research valuat price potenti us flavour cigar ban could
result canadian style event flavour cigar market us could see signific volum declin consum move
cigarett altern also increas uncertainti fda pmta process model volum declin
 respect realiti could turn wors addit risk could arriv us launch velo competitor swma zyn
product velo due launch summer could use price lever attract new custom would advers impact
effect altria manag
provid short-term bearish view
stock given see unsuccess
attempt sell us busi philip
morri p/core tobacco ep
indic us someth must
realli wrong us market
bat large-cap tobacco compani
 earn cut
perform stabl strategi henc
us e-cig slowdown bolster us cig
volum flavor e-cig ban help bat
us outperform consid
volum menthol cig
howev price-to-earnings bat
expens altria today p/core
imb stock wash post earn
warn end ceo
chairman leav time heighten
industri churn set strategi
valuat also support
price-to-earnings imb expens
unconvinc launch jt
ploom ploom japan
see littl evid jt abl
revers market share loss domest
pm us regulatori exposur
price-to-earnings one cheapest large-
cap stapl grow revenu
howev fail altria merger
manag narr
forese futur suffici vagu
left uncertainti mind
regul revenu
may headwind
flavor cigar file pmta
view unlik due cost
therefor expect
transitionari period swma portfolio
move away flavor cigar toward
altria access strongest brand
categori cig marlboro hnb
iqo e-cig juul moist smokeless
altria consist deliv ep
growth recent year variou
econom regulatori litig cycl
expect ep growth resum
bat continu perform well
combust consist
share gainer japan bat gain
share last year despit hnb
product distant second iqo
expect organ revenue growth
margin expans drive
ep compound-annual-growth-rate ex fx
stock cheap base price-to-earnings
appoint new chairman ceo
could lead commun strateg
jt domest busi unlik report
ebit growth next sever year
estim
tokyo olymp regul chang
around restaur abil serv food
area hnb custom bring renew
pressur iqo
exposur us
pm guid ex-fx revenu
growth put top end
fastest-grow stapl compani
view regulatori framework
acceler growth toward rrp pm
second-highest exposur rrp
revenu behind swma
zyn look well suit tobacco regul
aim product move consum
risk continuum without increas youth
preval popul risk
us model termin zyn ebit
margin believ
conserv estim consid altria
smokeless margin bat
thought ahead number
altria group inc mo quarterli annual ep usd
consensu number refinitiv receiv gmt
altria estim total domest cigarett industri volum declin
primarili due increas ga price factor believ impact adult
tobacco consum behaviour altria guid full-year adjust dilut ep
rang slightli refinitiv consensu line
barclay adj ep
result thing watch
accord ytd cig industri volum altria volum
declin lost share discount expect underli volum
declin report volum closer expect inventori
commentari around vape epidem ill impact cig volum
volum show sign improv could bolster investor confid
time hsr approv juul deal
initi recept iqo
altria support tobacco tax equiti act
expect cig volum declin vs earlier us cig industri
volum declin ytd report
estim adj dilut ep vs refinitiv consensu
make chang full-year estim
set price target altria base price-to-earnings valuat last two decad altria
trade averag forward multipl higher cigarett volum declin
manag attempt sell us busi p/core tobacco ep expect
pressur multipl near term valu altria price-to-earnings vs earlier add
addit valu per share juul crono get price target usd
note altria fail premium merger discuss impli share price
altria use pre-transact price pmi
chang estim
incl servic
revenu net excis tax
incl servic
incom statement summari usd million except per share figur year-end decemb
incl servic
revenu net excis tax
incl servic
incl servic
balanc sheet summari usd million year-end decemb
cash equival
properti plant equip
invest ab inbev/sabmil
current portion long-term debt
stockhold equiti attribut altria
flow summari usd million except per share figur year-end decemb
depreci amort
earn equiti invest ab
dividend ab inbev/sab miller
effect chang
accru liabil current asset
net cash provid oper activ
net cash use invest activ
repurchas common stock
dividend paid common stock
use financ activ
thought ahead number
inc pm quarterli annual ep usd
consensu number refinitiv receiv gmt
pmi estim total cigarett htu shipment volum declin like-for-
like basi pmi guid revenu ex fx growth least adjust
dilut ep ex fx growth least pmi constant currenc growth guidanc
least compar expect constant currenc growth
result thing watch
perform iqo key market japan europ especi
russia investor also keep eye perform iqo multi japan
korea
iqoss market share russia itali germani key european market citi
high market share vilniu would interest see stabil
investor keenli watch comment iqo respons us
overal volum perform cigarett heat tobacco unit
expect cig volum declin vs earlier vs
earlier expect total cig htu volum declin
note pmi deconsolid rbh canada march
estim report basi number improv slightli incorpor
canadian deconsolid appropri
estim adj dilut ep vs refinitiv consensu
updat fx rate close sep expect headwind
chang estim
incom statement summari usd million except per share figur year-end decemb
balanc sheet summari usd million year-end decemb
cash equival
properti plant equip
current portion long-term debt
flow summari usd million except per share figur year-end decemb
depreci amort
effect chang
accru liabil current asset
net cash provid oper activ
net cash use invest activ
short-term borrow activ origin matur
net issuanc matur day less
issuanc matur longer day
repay matur longer day
net cash use financ activ
thought ahead number
swedish match swma st financi valuat metric ep sek
consensu number refinitiv receiv gmt
compani chang guidanc us cigar busi compani
revis expect us cigar market modest growth volum
growth guidanc remain unchang
result thing watch
swma report oct fda due publish draft guidanc
ban flavor cigar oct investor focu swma believ
weather potenti headwind us cigar busi account
us progress zyn continu main driver stock commentari
around us competit dynam follow launch bat velo product juli
key
updat swma abil halt revers market share lose scandinavian
market focu manag
estim product group revenu sekm vs consensu sekm
forecast adj dilut ep sek vs consensu sek
zyn us volum can vs
chang estim
snu moist snuff
revenu net excis tax
snu moist snuff
snu moist snuff
snu moist snuff
zyn volum million can
incom statement sek million except per share figur
snu moist snuff
revenu net excis tax
snu moist snuff
snu moist snuff
snu moist snuff
balanc sheet sek million except per share figur
cash equival
properti plant equip
invest associ compani joint
loan borrow
stockhold equiti attribut swedish
flow oper activ
chang work capit
chang work capit
net cash provid oper activ
purchas properti plant equip
proce sale properti plant
purchas intang asset
net proce busi transfer stg
acquisit subsidiari net cash acquir
proce sale land
invest associ compani joint
divest associ compani joint
net cash use invest activ
repurchas common stock
dividend paid common stock
sek million except per share figur
use financ activ
thought ahead number
japan tobacco inc japay financi valuat metric ep usd
consensu number refinitiv receiv gmt
result jt cut guidanc jt cut japan revenu forecast
jpi ebit forecast jpi jt also lower reduc risk product
rrp volum forecast revis stick slightli reduc domest
cig volum forecast due share loss ebit forecast cut jpi
jpi due advers fx consolid ebit cut jpi
jpi
result thing watch
updat launch jt risk reduc product rrp ploom tech ploom
detail rate cannibalis ploom tech ploom legaci
market share develop domest cigarett busi particularli growth
valu segment
chang estim
revenu net excis tax
incom statement jpi billion except per share figur
revenu net excis tax
balanc sheet jpi billion except per share figur
cash equival
trade receiv
properti plant equip
trade payabl
bond borrow
bond borrow
compon equiti
jt
jpi billion except per share figur
earn continu oper
depreci amort
effect chang
trade payabl
net cash provid oper
purchas secur
proce sale redempt
purchas properti plant
proce sale properti plant
proce sale invest
purchas intang asset
payment busi combin
net cash use invest activ
dividend paid owner parent
dividend paid non-control
capit contribut non-control
increas decreas short-term
borrow commerci paper
proce long-term borrow
repay long-term borrow
proce issuanc bond
redempt bond
use financ activ
sometim oct-nov
sometim oct-nov
imb announc sale premium cigar busi
fda final draft guidanc ban flavour e-cig cigar sale
comment period requir warn cigarett packag advertis end
europ gb itali nielsen data
complet acquisit altria
fda fall agenda regulatori plan releas
comment period pmta requir e-cigarett tobacco product end
earli altria
stake juul
altria subject standstil agreement may acquir addit juul share
interest altria agre sell transfer juul common share six year close ftc
approv expect earli
pmta deadlin deem product e-cig cigar pipe tobacco hookah
restrict altria take-over juul end
tobacco-rel item hhs/fda spring agenda
stage rulemak
requir tobacco product manufactur practic
requir warn cigarett packag advertis
pre-market tobacco product applic recordkeep requir
tobacco product standard character flavor cigar
tobacco product standard nicotin level certain tobacco product request inform
end safeti standard includ standard toxic impur nicotin propylen
glycol veget glycerin use e-liquid tobacco product standard
offic inform regulatori affair
margin return data
flow balanc sheet mn
flow oper
flow invest
flow financ
equival
short long-term debt
valuat leverag metric
overweight altria signific price power
abil control cost altria consist
deliv ep growth recent year
variou econom regulatori litig cycl
expect ep growth resum
assum menthol ban affect
volum henc model slightli faster organ
growth appli price-to-earnings multipl deriv
upsid valuat usd
assum manag attempt sell
us busi p/core tobacco ep menthol
appli price-to-earnings multipl deriv downsid
valuat usd
overweight april pm trade
pe investor bought ex-fx
revenu compound-annual-growth-rate growth stori driven iqo
narr got sever derail japanes market
stall pm repeatedli cut iqo volum
toward higher end revenu growth
assum iqo reacceler due launch
new version iqo iqo multi
incorpor possibl iqo mesh e-
cig compet e-cigarett market appli
price-to-earnings multipl deriv upsid valuat
juul becom success intern
would creat signific overhang pmi iqo
strategi could pressur multipl appli
price-to-earnings multipl deriv downsid valuat
margin return data
flow balanc sheet mn
flow oper
flow invest
flow financ
equival
short long-term debt
valuat leverag metric
margin return data
flow balanc sheet sekmn
flow oper
flow invest
flow financ
equival
short long-term debt
valuat leverag metric
overweight swma us roll-out zyn
potenti signific catalyst growth
estim swma could growth organ
revenu compound-annual-growth-rate one fastest eu
stapl stock view potenti us flavor
cigar ban manag swma benefit
high qualiti earn reason leverag low
assum us flavour cigar ban either come
tabl impact benign swma
pursu aggress share buy-back programm
case expect stock re-rat price-to-earnings
assum us flavour cigar ban lead
neg volum growth seen canadian
market bat/rai product velo begin take
share zyn us market case
stock would de-rat price-to-earnings
margin return data
flow balanc sheet jpybn
flow oper
flow invest
flow financ
equival
short long-term debt
valuat leverag metric
underweight cautiou jt abil
report materi profit growth near-term
new risk-reduc product success expect
signific invest limit ebit growth
expect continu market share lose also
wari jt poor capit alloc record low
visibl growth busi
assum jt launch risk-reduc product
ploom logic success gener
share loss believ stock could re-rat
price-to-earnings
case jt risk-reduc product launch
unsuccess japan intern
would see jt continu lose market share
pressur stock could see de-rat price-to-earnings
imperi brand plc back ebit growth compani sep
imperi brand unexpect cut ep guidanc sep
pm-mo merger back sep
european consum stapl dank vape youth tobacco survey forc fda
confer feedback tilray cover sep
confer feedback cover sep
confer feedback crono group cover sep
european consum stapl pm-mo chang exchang ratio aug
british american tobacco plc fx emerg major tailwind aug
japan tobacco inc problem home aug
swedish match zyn larg off-set cigar woe juli
replay confer call audio transcript confer call mr
woodle kkb llp recent evolut tobacco cannabi
global stapl pictur juli
inc iqo back track upgrad ow juli
 british american tobacco earli pmta deadlin deem product
european consum stapl smoke signal second deriv us volum
turn posit watermelon blueberri juli
imperi brand announc opportunist share buy-back juli
activist ex-regul suggest juul/clos tank get regul over-the-counter drug june
fda cig nicotin reduct rulemak move glacial pace jun
pm fda author market iqo us cig reduc risk author still
smoke signal flavor ban work evid us e-cig data feb
mentholet analys possibl implic menthol ban dec
smoke signal kick tyre juul sep
smoke signal juul disrupt come tobacco juli
imperi brand initi heat burn may
gaurav jain herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
